New Sarms SR-9011

 

SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ.It has been used in the study of the regulation of the circadian rhythm and its links to immune system function, inflammation and cancer

 

Technical Data for SR-9011

M. Wt479.04
FormulaC23H31ClN4O3S
StorageStore at RT
Purity≥99% (HPLC)
CAS Number1379686-29-9
EINECS 1379686-290-9
AppearancePowder Form
Smiles

ClC(C=C1)=CC=C1CN(CC2CCN(C(NCCCCC)=O)C2)CC3=CC=C([N+]([O-])=O)S3

Solubility

  • DMF: 30 mg/ml
  • DMSO: 30 mg/ml
  • Ethanol: 14 mg/ml

Benifits of SR-9011

  • Helps grow bigger muscles
  • Helps in improving strength
  • Burns fat fast
  • Imcreas lean mass
  • Improves quick recovery

Share:

More Posts

Send Us A Message